The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study.
 
Irena Tan
No Relationships to Disclose
 
Tom Stinchcombe
Consulting or Advisory Role - AstraZeneca; Novartis; Regeneron; Takeda
Research Funding - AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Merck (Inst); Takeda (Inst)
 
Neal E. Ready
Honoraria - Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck
 
Michael B. Datto
No Relationships to Disclose
 
Rebecca J Nagy
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Lin Gu
No Relationships to Disclose
 
Jeffrey Melson Clarke
Consulting or Advisory Role - Inivata; Premier, Inc.
Speakers' Bureau - Guardant Health; Merck
Research Funding - Abbvie; Adaptimmune; Bristol-Myers Squibb; Genentech/Roche; medpacto; Moderna Therapeutics; Spectrum Pharmaceuticals